ArticleFrontiers in aging2025
Selenium intake is associated with gait speed in very old adults.
Article in Frontiers in aging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Selenium Deficiency is a Significant Risk Factor for Sarcopenia: Evidence and Selenoprotein-Mediated Mechanisms.Biological trace element research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Selenium seems to have protective effect on muscle function, contribute to healthy aging and longevity, however, in older adults this relationship has not been well studied. Objective: To evaluate the nutritional status of selenium in very old adults and its relationship with muscle strength, muscle mass and physical performance. Methods: A cross-sectional observational study investigating functionally independent individuals aged ≥80 years was conducted. Appendicular skeletal mass was determined by electrical bioimpedance, and physical performance and hand-grip strength were evaluated. Selenium intake and status in plasma and erythrocytes were evaluated. For statistical analysis. Poisson multivariate analysis was performed, and prevalence ratio used as a measure of effect. Results: A total of 72 older adults with a median age of 84 years were evaluated. Median Selenium intake was 71.58 mcg, and adequacy 73.5% overall, with a higher rate among men. In the total sample, 87.5% had optimal selenium plasma concentrations and no participants were deficient. All participants had adequate erythrocyte selenium levels. Gait speed was associated and correlated with selenium intake, even in the adjusted model The prevalence of low adequacy on the gait test was reduced by 3%-5% for every 1 mg increase in selenium consumption (PR 0.95; 95% CI: 0.93, 0.98). Conclusion: The gait speed results reinforce the hypothesis of an antioxidant role of selenium in muscle function. The very old adults studied demonstrated that homeostatic mechanisms control circulating selenium levels, highlighting the need for a specific reference value for the oldest-old population, besides the importance of analyzing blood markers associated with food intake and dietary patterns, since supplementation may prove iatrogenic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.